Associate director
Hartford Hospital
Disclosure(s): Abbvie: Honoraria; bioMeriuex: Advisor/Consultant, Grant/Research Support; Contrafect: Grant/Research Support; Entasis: Grant/Research Support; Merck and Co: Grant/Research Support; Roche Diagnostics: Grant/Research Support; Shionogi: Advisor/Consultant, Grant/Research Support, Honoraria; Summit: Grant/Research Support
Joseph L. Kuti, PharmD, FIDP is Associate Director of Clinical and Economic Studies at the Center for Anti-Infective Research and Development at Hartford Hospital in Hartford, Connecticut. Dr. Kuti received his Bachelor of Science and Doctor of Pharmacy degrees from Rutgers University, College of Pharmacy in Piscataway, New Jersey. While completing his doctorate, he served as a clinical pharmacist for the medical and surgical intensive care units at Robert Wood Johnson University Hospital in New Brunswick, New Jersey. He then completed a post-doctorate fellowship in Antibiotic Management and Pharmacoeconomics at Hartford Hospital. He is a member of the American Society for Microbiology, American College of Clinical Pharmacy, Infectious Disease Society of America, and past-President and honorary Fellow of the Society of Infectious Diseases Pharmacists. Dr Kuti’s primary area of research includes the pharmacokinetics, -dynamics, -economics, and outcomes of antimicrobial therapy in severe infections. His research has been published in over 200 peer-reviewed papers.